Compare $ALT vs $NGNE | Chartloom

Compare

$ALT vs $NGNE

Altimmune Inc · Neurogene Inc

ALT

Altimmune Inc

NGNE

Neurogene Inc

Compare $ALT vs $NGNE

Comparing Altimmune Inc and Neurogene Inc

ALTAltimmune Inc

NGNENeurogene Inc

ALTAltimmune Inc

Market cap

$508M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

55.0%

YTD performance

-25.6%

52W performance

-33.6%

FCF yield

-15.1%

NGNENeurogene Inc

Market cap

$521M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

31.0%

52W performance

2.2%

FCF yield

-16.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALT

NGNE

Detailed metrics comparison

ALT

Altimmune Inc

NGNE

Neurogene Inc

Market Cap

ALT$508M

NGNE$521M

Enterprise Value

ALT$479M

NGNE$409M

Price

ALT$2.61

NGNE$26.40

P/E Ratio

ALTN/A

NGNEN/A

P/S Ratio

ALT16,373.12x

NGNE0.00x

EV/Sales

ALT15,461.31x

NGNE0.00x

EV/EBITDA

ALT0.00x

NGNE0.00x

P/B Ratio

ALT1.12x

NGNE2.36x

P/FCF Ratio

ALTN/A

NGNEN/A

EV/FCF

ALT-6.26x

NGNE-4.66x

PEG Ratio

ALTN/A

NGNEN/A

Forward P/E (NTM)

ALTN/A

NGNEN/A

Forward P/S (NTM)

ALTN/A

NGNEN/A

Revenue (TTM)

ALT$31K

NGNE$0

Revenue Growth (YoY)

ALT55.0%

NGNEN/A

Forward Rev Growth

ALT217.1%

NGNE127.3%

Gross Margin (TTM)

ALT0.0%

NGNE0.0%

Operating Margin (TTM)

ALT0.0%

NGNE0.0%

EBITDA Margin (TTM)

ALT-322987.1%

NGNE0.0%

Net Margin (TTM)

ALT-296000.0%

NGNE0.0%

FCF Margin (TTM)

ALT-246974.2%

NGNEN/A

Net Income (TTM)

ALT$-92M

NGNE$-46M

FCF (TTM)

ALT$-77M

NGNE$-88M

EPS (TTM)

ALT-$0.49

NGNE$0.00

ROE (TTM)

ALT-3141.0%

NGNE-2527.0%

ROA (TTM)

ALT-2696.0%

NGNE-2325.0%

ROIC (TTM)

ALT-2853.0%

NGNE-2527.0%

Cash

ALT$63M

NGNE$112M

Debt

ALT$35M

NGNE$8K

Net Cash/Debt

ALT$28M

NGNE$112M

Current Ratio (TTM)

ALT26.78x

NGNE10.64x

Quick Ratio (TTM)

ALT26.37x

NGNE10.53x

Debt/Equity (TTM)

ALT0.07x

NGNE0.00x

Debt/Assets (TTM)

ALT0.0%

NGNE0.0%

Interest Coverage (TTM)

ALTN/A

NGNEN/A

Net Debt/EBITDA (TTM)

ALT0.00x

NGNE0.00x

Beta

ALT0.06

NGNE1.71

52W Performance

ALT-33.6%

NGNE2.2%

YTD Performance

ALT-25.6%

NGNE31.0%

% from 52W High

ALT-59.5%

NGNE-39.5%

% from 52W Low

ALT2.4%

NGNE65.7%

Asset Turnover (TTM)

ALT0.00x

NGNE0.00x

FCF Yield (TTM)

ALT-15.1%

NGNE-16.8%

Earnings Yield (TTM)

ALT-18.1%

NGNE-8.8%

Dividend Yield (TTM)

ALTN/A

NGNEN/A

Rule of 40

ALT-246,919.2

NGNE0.0

EV/GP/RG

ALTN/A

NGNEN/A

Ticker research

View ALT research View NGNE research

Metric	ALT Altimmune Inc	NGNE Neurogene Inc
Market & Valuation
Market Cap	$508M	$521M
Enterprise Value	$479M	$409M
Price	$2.61	$26.40
P/E Ratio	N/A	N/A
P/S Ratio	16,373.12x	0.00x
EV/Sales	15,461.31x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.12x	2.36x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.26x	-4.66x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$31K	$0
Revenue Growth (YoY)	55.0%	N/A
Forward Rev Growth	217.1%	127.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-322987.1%	0.0%
Net Margin (TTM)	-296000.0%	0.0%
FCF Margin (TTM)	-246974.2%	N/A
Net Income (TTM)	$-92M	$-46M
FCF (TTM)	$-77M	$-88M
EPS (TTM)	-$0.49	$0.00
ROE (TTM)	-3141.0%	-2527.0%
ROA (TTM)	-2696.0%	-2325.0%
ROIC (TTM)	-2853.0%	-2527.0%
Financial Health
Cash	$63M	$112M
Debt	$35M	$8K
Net Cash/Debt	$28M	$112M
Current Ratio (TTM)	26.78x	10.64x
Quick Ratio (TTM)	26.37x	10.53x
Debt/Equity (TTM)	0.07x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.06	1.71
52W Performance	-33.6%	2.2%
YTD Performance	-25.6%	31.0%
% from 52W High	-59.5%	-39.5%
% from 52W Low	2.4%	65.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-15.1%	-16.8%
Earnings Yield (TTM)	-18.1%	-8.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-246,919.2	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ALT research	View NGNE research

Valuation

P/S Ratio

NGNE

0.00x

ALT

16,373.12x

EV/FCF

ALT

-6.26x

NGNE

-4.66x

Growth & revenue

Revenue Growth TTM

ALT

55.0%

Forward Revenue Growth

ALT

217.1%

NGNE

127.3%

Profitability & performance

Gross Margin

ALT

0.0%

NGNE

0.0%

ROE

NGNE

-2527.0%

ALT

-3141.0%

FCF Yield %

ALT

-15.1%

NGNE

-16.8%

52-Week Performance

NGNE

2.2%

ALT

-33.6%

Detailed metrics comparison

ALT

Altimmune Inc

NGNE

Neurogene Inc

Market Cap

ALT$508M

NGNE$521M

Enterprise Value

ALT$479M

NGNE$409M

Price

ALT$2.61

NGNE$26.40

P/E Ratio

ALTN/A

NGNEN/A

P/S Ratio

ALT16,373.12x

NGNE0.00x

EV/Sales

ALT15,461.31x

NGNE0.00x

EV/EBITDA

ALT0.00x

NGNE0.00x

P/B Ratio

ALT1.12x

NGNE2.36x

P/FCF Ratio

ALTN/A

NGNEN/A

EV/FCF

ALT-6.26x

NGNE-4.66x

PEG Ratio

ALTN/A

NGNEN/A

Forward P/E (NTM)

ALTN/A

NGNEN/A

Forward P/S (NTM)

ALTN/A

NGNEN/A

Revenue (TTM)

ALT$31K

NGNE$0

Revenue Growth (YoY)

ALT55.0%

NGNEN/A

Forward Rev Growth

ALT217.1%

NGNE127.3%

Gross Margin (TTM)

ALT0.0%

NGNE0.0%

Operating Margin (TTM)

ALT0.0%

NGNE0.0%

EBITDA Margin (TTM)

ALT-322987.1%

NGNE0.0%

Net Margin (TTM)

ALT-296000.0%

NGNE0.0%

FCF Margin (TTM)

ALT-246974.2%

NGNEN/A

Net Income (TTM)

ALT$-92M

NGNE$-46M

FCF (TTM)

ALT$-77M

NGNE$-88M

EPS (TTM)

ALT-$0.49

NGNE$0.00

ROE (TTM)

ALT-3141.0%

NGNE-2527.0%

ROA (TTM)

ALT-2696.0%

NGNE-2325.0%

ROIC (TTM)

ALT-2853.0%

NGNE-2527.0%

Cash

ALT$63M

NGNE$112M

Debt

ALT$35M

NGNE$8K

Net Cash/Debt

ALT$28M

NGNE$112M

Current Ratio (TTM)

ALT26.78x

NGNE10.64x

Quick Ratio (TTM)

ALT26.37x

NGNE10.53x

Debt/Equity (TTM)

ALT0.07x

NGNE0.00x

Debt/Assets (TTM)

ALT0.0%

NGNE0.0%

Interest Coverage (TTM)

ALTN/A

NGNEN/A

Net Debt/EBITDA (TTM)

ALT0.00x

NGNE0.00x

Beta

ALT0.06

NGNE1.71

52W Performance

ALT-33.6%

NGNE2.2%

YTD Performance

ALT-25.6%

NGNE31.0%

% from 52W High

ALT-59.5%

NGNE-39.5%

% from 52W Low

ALT2.4%

NGNE65.7%

Asset Turnover (TTM)

ALT0.00x

NGNE0.00x

FCF Yield (TTM)

ALT-15.1%

NGNE-16.8%

Earnings Yield (TTM)

ALT-18.1%

NGNE-8.8%

Dividend Yield (TTM)

ALTN/A

NGNEN/A

Rule of 40

ALT-246,919.2

NGNE0.0

EV/GP/RG

ALTN/A

NGNEN/A

Ticker research

View ALT research View NGNE research

Metric	ALT Altimmune Inc	NGNE Neurogene Inc
Market & Valuation
Market Cap	$508M	$521M
Enterprise Value	$479M	$409M
Price	$2.61	$26.40
P/E Ratio	N/A	N/A
P/S Ratio	16,373.12x	0.00x
EV/Sales	15,461.31x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.12x	2.36x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.26x	-4.66x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$31K	$0
Revenue Growth (YoY)	55.0%	N/A
Forward Rev Growth	217.1%	127.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-322987.1%	0.0%
Net Margin (TTM)	-296000.0%	0.0%
FCF Margin (TTM)	-246974.2%	N/A
Net Income (TTM)	$-92M	$-46M
FCF (TTM)	$-77M	$-88M
EPS (TTM)	-$0.49	$0.00
ROE (TTM)	-3141.0%	-2527.0%
ROA (TTM)	-2696.0%	-2325.0%
ROIC (TTM)	-2853.0%	-2527.0%
Financial Health
Cash	$63M	$112M
Debt	$35M	$8K
Net Cash/Debt	$28M	$112M
Current Ratio (TTM)	26.78x	10.64x
Quick Ratio (TTM)	26.37x	10.53x
Debt/Equity (TTM)	0.07x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.06	1.71
52W Performance	-33.6%	2.2%
YTD Performance	-25.6%	31.0%
% from 52W High	-59.5%	-39.5%
% from 52W Low	2.4%	65.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-15.1%	-16.8%
Earnings Yield (TTM)	-18.1%	-8.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-246,919.2	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ALT research	View NGNE research